StrandGH Surge 10mg

• Extended-Release Pulsatile Action — DAC technology sustains GH secretion over days, mimicking natural rhythms for enhanced research outcomes.
• GH/IGF-1 Elevation — Investigated for boosting anabolic signaling, protein synthesis, and lipolysis in metabolic and recovery studies.
• Prolonged Half-Life — Up to 8 days of activity, reducing injection frequency while maintaining steady hormone modulation.
• High Purity & USA-Made — Synthesized to pharmaceutical-grade standards with full third-party validation and traceability.
• Convenient 10mg Vial — Perfect for multi-week research cycles, delivering value and dosing flexibility.
• Coastal-Inspired Branding — From the Strand family, symbolizing a surging wave of hormonal vitality and performance potential.

• Active: CJC-1295 with DAC – 10mg per vial Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln (with DAC modification at Lys20) Molecular Formula: C₁₆₅H₂₆₉N₄₇O₄₆ Molecular Weight: ~3647.21 g/mol (without DAC; extended via complex)
• Form: Lyophilized (freeze-dried) powder for reconstitution
• Purity: ≥99% (verified via HPLC and third-party testing; certificate of analysis available upon request)
• Other: No additional fillers, additives, or preservatives – research-grade only

For laboratory and research purposes only. Reconstitute the 10mg vial with bacteriostatic water (typically 1-2mL) to create a stable solution (e.g., 5mg/mL concentration). Common research protocols involve subcutaneous administration, with investigative dosages ranging from 1-2mg per week (e.g., 1mg twice weekly, split for pulsatile effects). Store lyophilized powder at -20°C (freezer) for long-term stability; after reconstitution, refrigerate at 2-8°C and use within 4-6 weeks to preserve bioactivity. Adhere to sterile techniques and institutional protocols for handling and dosing in experimental settings.

• Research Use Only — Not for human consumption, diagnostic, therapeutic, or medical use. This product is sold strictly for in vitro laboratory research and educational purposes.
• Not FDA-Approved — CJC-1295 with DAC is an investigational peptide with no established therapeutic approval for human use. No claims are made regarding safety or efficacy in humans.
• Potential Risks — Limited long-term human data; may influence hormone levels—monitor in research models for imbalances (e.g., elevated IGF-1). Source only from verified suppliers with COAs to ensure quality.
• Storage & Handling — Keep out of reach of children/pets. Protect from light, heat, or moisture. Use aseptic methods for reconstitution and administration in controlled environments.
• Legal Note — Comply with local regulations; may be restricted in competitive sports or certain jurisdictions. Grand Strand Supplements disclaims liability for off-label or improper use.